Background Controversy persists about the optimal approach to drug-based control of
schistosomiasis in high-risk communities. In a systematic review of published studies, we …

Infectious diseases caused by parasites are a major threat for the entire mankind, especially
in the tropics. More than 1 billion people world-wide are directly exposed to tropical …

Background Children carry most of the schistosomiasis burden. While school-aged children
are the principal target group of preventive chemotherapy with praziquantel, limited …

Schistosomiasis is a snail-borne disease caused by worms of the genus Schistosoma.
Worldwide, human schistosomiasis remains a serious public health problem, threatening∼ …

Schistosomiasis control is heavily reliant on the drug praziquantel (PZQ), which is used as
preventive chemotherapy as part of national helminth control strategies. Given the heavy …

The stumbling block for the continued, single-drug use of praziquantel (PZQ) against
schistosomiasis is less justified by the risk of drug resistance than by the fact that this drug is …

The regular administration of the anthelminthic drug praziquantel (PZQ) to school-aged
children (and other high-risk groups) is the cornerstone of schistosomiasis control. Whilst the …

Schistosomiasis is a debilitating disease affecting approximately 600 million people in 74
developing countries, with 800 million, mostly children at risk. To circumvent the threat of …

Background. Schistosomiasis is among the most widespread chronic infections in the world.
The magnitude of the infection may show variations across different areas with respect to …

Schistosomiasis has plagued the Egyptian population since the antiquity. The disease is still
a public health problem in Egypt, despite the tendency of being overlooked. In the first part of …